Evaluation of Vertical Bone Gain After Ridge Augmentation With APRF & Xenograft Vs Collagen Membr… (NCT03855852) | Clinical Trial Compass
UnknownNot Applicable
Evaluation of Vertical Bone Gain After Ridge Augmentation With APRF & Xenograft Vs Collagen Membrane & Xenograft. RCT
Egypt20 participantsStarted 2019-02-01
Plain-language summary
Comparative study for evaluation of vertical bone gain after one stage ridge augmentation with advanced platelet rich fibrin (A-PRF) and xenograft versus guided bone regeneration using collagen membrane and xenograft.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* At least 18 years old.
* Systemically healthy.
* Has good dental health.
* Missing a single tooth in the maxillary anterior and premolar region
* Crestal residual ridge width of 4-5mm.
* Residual ridge with an adequate band of keratinized tissue (2 mm).
* Residual ridge with sufficient vertical bone height to safely place a \>10 mm long dental implant.
Exclusion Criteria:
* Severe parafunctional habits, for example, bruxing and clenching.
* Conditions that complicate wound healing, for example, uncontrolled diabetes (defined as HBA1c level \>7%) or smoking.
* Conditions that might lead to a possibly lowered regenerative capacity of the bone, for example, osteoporosis and Paget's disease.
* Pregnant or expecting to be pregnant.
* History of drug and alcohol abuse or certain medications like bisphosphonates or steroids currently or within the past three months.